Warm-up of the Inspiratory Musculature and Its Impact in Swimming Performance
Warm-up of the Inspiratory Musculature and Its Impact on Physiological Parameters and Swimming Performance: Exploration of Intensities Based on Maximal Inspiratory Pressure
Objective To evaluate the acute effect of four inspiratory warm-up intensities (15%, 40%, 60%, and 80% of maximal inspiratory pressure [MIP]) on 100 m freestyle performance, and to analyze their impact on heart rate, blood lactate concentration, perceived exertion, and dyspnea in trained swimmers.
Methods A randomized, crossover, double-blind experimental study was conducted. Participants were swimmers aged ≥18 years, with no respiratory or musculoskeletal pathology.
Each participant completed, in sessions separated by at least three days, an inspiratory muscle warm-up consisting of 30 breaths against resistive loads set at 15%, 40%, 60%, and 80% of their MIP, previously determined using standardized procedures.
Following each intervention, participants performed a maximal 100 m freestyle test. The following variables were recorded:
Swimming time Heart rate (during and post-exercise) Post-exercise capillary blood lactate concentration Rating of perceived exertion (Borg scale) Dyspnea (Dyspnea-12)
Conclusions This study will help identify the optimal inspiratory warm-up intensity to enhance swimming performance.
調査の概要
詳細な説明
Inspiratory warm-up
An intervention performed prior to exercise consisting of breathing against resistance to activate the inspiratory muscles (mainly the diaphragm and accessory respiratory muscles) with the aim of enhancing their performance during subsequent effort.
Maximal Inspiratory Pressure (MIP)
The maximum pressure that an individual can generate during a forceful inspiration against an occluded airway. It is an indicator of inspiratory muscle strength and is used to prescribe training intensity.
Relative intensities (15%, 40%, 60%, 80% of MIP)
Percentages of MIP representing different levels of respiratory workload. They allow graded inspiratory resistance to investigate dose-response effects on performance.
Inspiratory Muscle Training (IMT)
A specific training method targeting the inspiratory muscles through controlled resistive breathing loads, aimed at improving strength, endurance, and ventilatory efficiency.
Crossover design
An experimental design in which each participant completes all experimental conditions, acting as their own control, thereby reducing inter-subject variability.
Double-blind design
A methodological approach in which neither participants nor evaluators are aware of the assigned condition, minimizing bias in performance and outcome assessment.
Swimming performance
A functional outcome measured primarily through time to complete a fixed distance, in this case 100 meters freestyle.
Cardiovascular response
The physiological response of the cardiovascular system to exercise, typically assessed through heart rate and post-exercise recovery dynamics.
Blood lactate concentration
A marker of metabolic stress during high-intensity exercise, reflecting the contribution of anaerobic glycolysis to energy production.
Perceived exertion
A subjective assessment of exercise intensity, commonly measured using standardized scales such as the Borg scale.
Respiratory discomfort (dyspnea)
A subjective sensation of breathing difficulty associated with exertion, reflecting ventilatory demand and exercise tolerance.
研究の種類
入学 (推定)
段階
- 適用できない
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion criteria:
- Participants of both sexes, aged over 18 years.
- Minimum swimming training frequency of at least two sessions per week, with a minimum duration of 30 minutes per session, consistently maintained over the last three months.
Exclusion criteria:
- Current or previous diagnosis of respiratory diseases.
- Musculoskeletal injuries limiting the ability to perform a 100-meter swimming test.
- Participation in inspiratory muscle training programs within the last six months.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：クロスオーバー割り当て
- マスキング：ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：IMT: 15%
The study will apply four respiratory warm-up intensities (15%, 40%, 60%, and 80% of maximal inspiratory pressure) to compare their acute effects on these variables.
This graded loading approach will allow identification of the optimal dose capable of maximizing diaphragmatic neuromuscular activation without inducing early fatigue, leveraging the post-activation potentiation phenomenon to improve respiratory efficiency and swimming performance.
|
It is a crossover study in which the different exercise intensities are investigated.
|
|
実験的：IMT:40%
The study will apply four respiratory warm-up intensities (15%, 40%, 60%, and 80% of maximal inspiratory pressure) to compare their acute effects on these variables.
This graded loading approach will allow identification of the optimal dose capable of maximizing diaphragmatic neuromuscular activation without inducing early fatigue, leveraging the post-activation potentiation phenomenon to improve respiratory efficiency and swimming performance.
|
It is a crossover study in which the different exercise intensities are investigated.
|
|
実験的：IMT: 60%
The study will apply four respiratory warm-up intensities (15%, 40%, 60%, and 80% of maximal inspiratory pressure) to compare their acute effects on these variables.
This graded loading approach will allow identification of the optimal dose capable of maximizing diaphragmatic neuromuscular activation without inducing early fatigue, leveraging the post-activation potentiation phenomenon to improve respiratory efficiency and swimming performance.
|
It is a crossover study in which the different exercise intensities are investigated.
|
|
実験的：IMT: 80%
The study will apply four respiratory warm-up intensities (15%, 40%, 60%, and 80% of maximal inspiratory pressure) to compare their acute effects on these variables.
This graded loading approach will allow identification of the optimal dose capable of maximizing diaphragmatic neuromuscular activation without inducing early fatigue, leveraging the post-activation potentiation phenomenon to improve respiratory efficiency and swimming performance.
|
It is a crossover study in which the different exercise intensities are investigated.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
swimming time (100 meters)
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
After the respiratory interventions, participants will perform a maximal 100-meter freestyle swimming test under supervision.
The total time will be recorded using a digital stopwatch, starting with the starting signal and ending when the swimmer touches the wall upon completing the distance.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Maximal Inspiratory Pressure and Maximal Expiratory Pressure
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Maximal Inspiratory Pressure (PIM/MIP) and Maximal Expiratory Pressure (PEM/MEP) are indicators of global respiratory muscle strength.
PIM reflects the maximal negative pressure generated during a forced inspiratory effort against an occluded airway, mainly assessing diaphragmatic and external intercostal muscle function, whereas PEM reflects the maximal positive pressure produced during a forced expiratory effort, mainly involving abdominal and internal intercostal muscles.
Both variables are expressed in centimeters of water (cmH₂O) and are widely used to quantify inspiratory and expiratory muscle performance, as well as to evaluate respiratory muscle fatigue and training adaptations in clinical and sports settings.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Lactate
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Immediately after the test, blood lactate will be measured using a Lactate Pro 2 portable analyzer, from a capillary blood sample obtained from the fingertip.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Perceived exertion.
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Perceived exertion will be assessed using the Borg scale (6-20), previously explained to ensure proper understanding, and will be recorded immediately after exercise through a direct interview.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Dysnea
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
The Dyspnea-12 (D-12) scale is a multidimensional questionnaire used to assess the severity and qualitative perception of dyspnea (breathlessness). It evaluates both the physical and emotional components associated with breathing discomfort. The questionnaire consists of 12 items: My breath does not go in all the way My breathing requires more work I feel short of breath I have difficulty catching my breath I cannot get enough air My breathing is uncomfortable My breathing is exhausting My breathing makes me feel depressed My breathing makes me feel miserable My breathing is distressing My breathing makes me agitated My breathing is irritating Each item is scored using a 4-point Likert scale: 0 = None
Therefore, the total score ranges from 0 to 36 points. Interpretation: A low score indicates little or no perceived dyspnea. A moderate score reflects clinically relevant breathing discomfort. A high score indicates severe dyspnea with an important |
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Heart rate.
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Heart rate will be continuously monitored during the test and for up to five minutes post-exercise using a Polar H10 chest strap, placed on the anterior thoracic region just below the xiphoid process.
The device will be calibrated before each session, and data will be analyzed using Polar Flow software to obtain parameters such as mean heart rate, maximum heart rate, which are key indicators of autonomic and cardiovascular response to exercise.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Recovery time
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Recovery time will be defined as the period required for heart rate to decrease following the cessation of exercise.
This parameter reflects autonomic nervous system recovery, particularly parasympathetic reactivation after physical exertion.
Heart rate recovery will be analyzed during the first five minutes post-exercise using data collected from the Polar H10 device.
Faster recovery times are generally associated with better cardiovascular fitness and autonomic regulation, whereas delayed recovery may indicate increased physiological stress or fatigue.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Heart rate variability
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Heart rate variability (HRV) refers to the variation in the time intervals between consecutive heartbeats (R-R intervals).
HRV is considered a non-invasive marker of autonomic nervous system activity and reflects the balance between sympathetic and parasympathetic modulation.
HRV data obtained from the Polar H10 sensor will be analyzed using Polar Flow software, and parameters such as RMSSD and SDNN may be extracted.
Higher HRV values are typically associated with better autonomic adaptability and recovery capacity, while lower values may reflect fatigue, stress, or reduced physiological adaptability.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
|
Forced Vital Capacity and Forced Expiratory Volume in 1 second
時間枠：This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
Forced Vital Capacity (FVC/CVF) and Forced Expiratory Volume in 1 second (FEV₁) are spirometric measures used to assess ventilatory capacity and pulmonary function.
FVC represents the total volume of air that can be forcibly exhaled after a maximal inspiration, expressed in liters (L), while FEV₁ represents the volume exhaled during the first second of that maneuver, also expressed in liters.
The FEV₁/FVC ratio is commonly used to identify ventilatory limitations, particularly obstructive patterns.
Together, these variables provide key information on airway function, expiratory flow limitation, and overall pulmonary performance.
|
This measurement will be carried out from the randomization process until 8 weeks after the start of the inspiratory training program.
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 100220261562026
- Sponsor-Investigator (その他の識別子：Agustín Velázquez Córdoba)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
At present, no definitive decision has been made regarding the sharing of individual participant data. On the one hand, making anonymized data available could enhance scientific transparency, reproducibility of results, and the development of new research lines based on the collected data.
However, several relevant aspects are also considered, such as the protection of participant confidentiality, strict compliance with applicable data protection regulations (GDPR), and the need to ensure appropriate and controlled use of the information. Additionally, the potential limitations related to sample size and the specific context of the study are taken into account.
If data sharing is ultimately implemented, it would be provided exclusively in anonymized format, upon justified request, following appropriate project evaluation and, where applicable, through formal data use agreements.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。